Maternal infection and white matter toxicity

NeuroToxicology

Volumn 27, Issue 5, 2006, Pages 658-670

  Harry, G Jean ^a   Lawler, Cindy ^a   Brunssen, Susan H ^a,b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Microglia; Oligodendrocyte; White matter damage

Indexed keywords

ARTICLE; AUTISM; BRAIN DAMAGE; BRAIN DEVELOPMENT; CHORIOAMNIONITIS; DISEASE PREDISPOSITION; GESTATIONAL AGE; HUMAN; IMMUNE STATUS; IMMUNOCOMPETENT CELL; INFECTION; INFLAMMATION; LOW BIRTH WEIGHT; MACROPHAGE; MATERNAL DISEASE; MICROGLIA; MYELINATION; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PERINATAL INFECTION; PHAGOCYTE; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROGENY; RISK FACTOR; SCHIZOPHRENIA; WHITE MATTER;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; NERVOUS SYSTEM DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 33747394460     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2006.05.004     Document Type: Article

References (192)

1. Åberg K., Saetre P., Lindholm E., Ekholm B., Pettersson U., Adolfsson R., et al. Human QKI, a new candidate gene for schizophrenia involved in myelination. Am J Med Genet Part B: Neuropsychiat Genet 141B (2005) 84-90
2. Abernethy L.J., Palaniappan M., and Cooke R.W. Quantitative magnetic resonance imaging of the brain in survivors of very low birth weight. Arch Dis Child 87 (2002) 279-283
3. Adams W., Kendell R.E., Hare E.H., and Munk-Jorgensen P. Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data. Brit J Psychiatry 163 (1993) 522-534
4. Aloisi F., Serafini B., and Adorini L. Glia-T cell dialogue. J Neuroimunol 107 (2000) 111-117
5. Andersen H., and Matthiessen M.E. The histiocyte in human foetal tissue: its morphology, cytochemistry, origin, function and fate. Z Zellforsch 72 (1966) 193-212
6. Andreasen N., Paradiso S., and O'Leary D. Cognitive dysmetria as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?. Schizophrenia Bull 24 (1998) 203-218
7. Arntzen K.J., Kjollesdal A.M., Halgunset J., Vatten L., and Austgulen R. TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med 26 (1998) 17-26
8. Aston C., Jiang L., and Sokolov B.P. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77 (2004) 858-866
9. Azumagawa K., Suzuki S., Tanabe T., Wakamiya E., Kawamura N., and Tamai H. Neopterin, biopterin, and nitric oxide concentrations in the cerebrospinal fluid of children with central nervous system infections. Brain Dev 25 (2003) 200-202
10. Back S.A., and Rivkees S.A. Emerging concepts in periventricular white matter injury. Semin Perinatol 28 (2004) 405-414
11. Barnea-Goraly N., Kwon H., Menon V., Eliez S., Lotspeich L., and Reiss A.L. White matter structure in autism: preliminary evidence from diffusion tensor imaging. Biol Psychiatry 55 (2004) 323-326
12. Bartzokis G. Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology 27 (2002) 672-683
13. Baud O., Emilie D., Pelletier E., Lacaze-Masmonteil T., Zupan V., Fernandez H., et al. Amniotic fluid concentrations of interleukin-1beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: histological associations and neonatal outcome. Brit J Obstetr Gynaecol 106 (1999) 72-77
14. Baumann N., and Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81 (2001) 871-927
15. Belayev L., Ginsberg M.D., Alonso O.F., Singer J.T., Zhao W., and Busto R. Bilateral ischemic tolerance of rat hippocampus induced by prior unilateral transient focal ischemia: relationship to c-fos mRNA expression. Neuroreport 8 (1996) 55-59
16. Bell M.J., Hallenbeck J.M., and Gallo V. Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr Res 56 (2004) 541-546
17. Bennett F.C., and Scott D.T. Long-term perspective on premature infant outcome and contemporary intervention issues. J Perinatol 21 (1997) 190-201
18. Blumenthal I. Periventricular leukomalacia: a review. Eur J Pediatr 163 (2004) 435-442
19. Borrell J., Vela J.M., Arevalo-Martin A., Molina-Holgado E., and Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etipathogenesis of schizophrenia. Neuropsychopharm 26 (2002) 204-215
20. Brown A., and Susser E. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 8 (2002) 51-57
21. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61 (2004) 774-780
22. Brown A.S., Hooton J., Schaefer C.A., Zhang H., Petkova E., Babulas V., et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 161 (2004) 889-895
23. Brown A.S., Schaefer C.A., Wyatt R.J., Goetz R., Begg M.D., Gorman J.M., et al. Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophrenia Bull 26 (2000) 287-295
24. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D., and Yolken R.H. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 58 (2001) 1032-1037
25. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Wagner R.L., and Yolken R.H. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 15 (2001) 411-420
26. Cai Z., Pan Z.L., Pang Y., Evans O.B., and Rhodes P.G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 47 (2000) 64-72
27. Carson M.J., Reily C.R., Sutcliffe J.G., and Lo D. Mature microglia resemble immature antigen-presenting cells. Glia 22 (1998) 72-85
28. Chaiworapongsa T., Romero R., Kim J.C., Kim Y.M., Blackwell S.C., Yoon B.H., et al. Evidence for fetal involvement in the pathologic process of clinical chorioamnionitis. Am J Obstetr Gynecol 186 (2002) 1182-1187
29. Chandran S., Kato H., Gerreli D., Compston A., Svendsen C.N., and Allen N.D. FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway. Development 130 (2003) 6599-6609
30. Chess S., Fernandez P., and Korn S. Behavioral consequences of congenital rubella. J Pediatry 93 (1978) 699-703
31. Choe J., and Choi Y.S. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur J Immunol 28 (1998) 508-515
32. Corbin J., Kelly D., Rath E., Baerwald K., Suzuki K., and Popko B. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7 (1996) 354-370
33. Cosentino M., Fietta A., Caldiroli E., Marino F., Rispoli L., Comelli M., et al. Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy. Prog Neuropsychopharmacol Biol Psychiatry 20 (1996) 1117-1129
34. Cotter D.R., Mackay D., Beasley C.L., Everall I., and Landau S. The density, size and spatial pattern distribution of neurons and glia in area nine prefrontal cortex in schizophrenia, bipolar disorder and major depression. Schizophr Res 53 (2002) 107-108
35. Cotter D.R., Pariante C.M., and Everall I.P. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 55 (2001) 585-595
36. Counsell S.J., Shen Y., Boardman J.P., Larkman D.J., Kapellou O., Ward P., et al. Axial and radial diffusivity in preterm infants who have diffuse white matter changes on magnetic resonance imaging at term-equivalent age. Pediatrics 117 (2006) 376-386
37. Courchesne E., and Pierce K. Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. Int J Devel Neurosci 23 (2005) 153-170
38. Creasy R., and Resnik R. Maternal-fetal medicine: principles and practice. 5th ed. (2004), WB Saunders, Philadelphia
39. Crow T. Schizophrenia as a transcallosal misconnection syndrome. Schizophrenia Res 30 (1998) 111-114
40. Dalman C., Allebeck P., Cullberg J., Grunewald C., and Koster M. Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch Gen Psychiatry 56 (1999) 234-240
41. Dammann O., and Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42 (1997) 1-8
42. Dammann O., Kuban K.C., and Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev 8 (2002) 46-50
43. Dammann O., Leviton A., Gappa M., and Dammann C.E. Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long term outcome. Brit J Obstet Gynecol 112 Suppl. 1 (2005) 4-9
44. Dammann O., Phillips T.M., Allred E.N., O'Shea T.M., Paneth N., Van Marter L.J., et al. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine 13 (2001) 234-239
45. Davis K., Stewart D., Friedman J., Buchsbaum M., Harvey P.D., Hof P.R., et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archiv Gen Psychiatry 60 (2003) 443-456
46. Denney D.R., Frei B.W., and Gaffney G.R. Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord 26 (1996) 87-97
47. Duggan P.J., Maalouf E.F., Watts T.L., Sullivan M.H., Counsell S.J., Allsop J., et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 358 (2001) 1699-1700
48. Duncan J.R., Cock M.L., Scheerlinck J.P., Westcott K.T., McLean C., Harding R., et al. White matter injury after repeated endotoxin exposures in the preterm ovine fetus. Pediatr Res 52 (2002) 941-949
49. Edgar J.M., McLaughlin M., Yool D., Zhang S.C., Fowler J.H., Montague P., et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166 (2004) 121-131
50. Eklind S., Arvidsson P., Hagberg H., and Mallard C. The role of glucose in brain injury following the combination of lipopolysaccharide or lipoteichoic acid and hypoxia-ischemia in neonatal rats. Dev Neurosci 26 (2004) 61-67
51. Eklind S., Mallard C., Arvidsson P., and Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res 58 (2005) 112-116
52. Eklind S., Mallard C., Leverin A.L., Gilland E., Blomgren K., Mattsby-Baltzer I., et al. Bacterial endotoxin sensitizes the immature brain to hypoxia-ischemic injury. Eur J Neurosci 13 (2001) 1101-1106
53. Elovitz M.A., Mrinalini C., and Sammmel M.D. Elucidating the early signal transduction pathways leading to fetal brain injury in preterm birth. Pediatr Res 59 (2006) 50-55
54. Falkai P., Schneider-Axmann T., Honer W.G., Vogeley K., Schönell H., Pfeiffer U., et al. Influence of genetic loading, obstetric complications and premorbid adjustment on brain morphology in schizophrenia: a MRI study. Eur Arch Psychiatry Clin Neurosci 253 (2003) 92-99
55. Fan L.W., Pang Y., Liu S., Rhodes P.G., and Cai Z. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 133 (2005) 159-168
56. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 22 (2002) 25-33
57. Flynn S.W., Lang D.J., Mackay A.L., Goghari V., Vavasour I.M., Whittall K.P., et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry 8 (2003) 811-820
58. Folkerth R.D. Neuropathologic substrate of cerebral palsy. J Child Neurol 20 (2005) 940-949
59. Folkerth R.D., Keefe R.J., Haynes R.L., Trachtenberg F.L., Volpe J.J., and Kinney H.C. Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol 14 (2004) 265-274
60. Fombonne E. The epidemiology of autism: a review. Psychol Med 29 (1999) 769-786
61. Fortier M.E., Joober R., Luheshi G.N., and Boksa P. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatry Res 38 (2004) 335-345
62. Gadient R.A., and Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 637 (1994) 10-14
63. Gadient R.A., and Otten U.H. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog Neurobiol 52 (1997) 379-390
64. Gayle D.A., Beloosesky R., Desai M., Amidi F., Nunez S.E., and Ross M.G. Maternal LPS induces cytokines in the amniotic fluid and corticotropin-releasing hormone in the fetal rat brain. Am J Physiol Regul Integr Comp Physiol 266 (2004) R1024-R1029
65. Gehrmann J., and Kreutzberg G.W. Microglia in experimental neuropathology. In: Kettenmann H., and Ransom B. (Eds). Neuroglia (1995), Oxford University Press, Oxford 883-904
66. Gillberg I.C. Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for childhood autism. Dev Med Child Neurol 33 (1991) 920-924
67. Gilmore J.H., Jarskog L.F., and Vadlamudi S. Maternal infection regulates BDNF and NFG expression in fetal and neonatal brain and maternal-fetal unit of the rat. J Neuroimmunol 138 (2003) 49-55
68. Gilmore J.H., Jarskog F.L., Vadlamudi S., and Lauder J.M. Prenatal infection and risk for schizophrenia: IL-1β, IL-6, and TNFα inhibit cortical neuron dendrite development. Neuropsychopharmacology 29 (2004) 1221-1229
69. Gomez R., Romero R., Ghezzi F., Yoon B.H., Maxor M., and Berry S.M. The fetal inflammatory response syndrome. Am J Obstet Gynecol 179 (1998) 194-202
70. Gottesman I.I. Schizophrenia genesis: the origin of madness (1991), Freeman, New York
71. Gottesman I.I., and Shields J. A polygenic theory of schizophrenia. Proc Natl Acad Sci USA 58 (1967) 199-205
72. Greig P.C., Ernest J.M., Teot L., Erikson M., and Talley R. Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol 169 (1993) 1035-1044
73. Gucer F., Balkanli-Kaplan P., Yuksel M., Yuce M.A., Ture M., and Yardim T. Maternal serum tumor necrosis factor-alpha in patients with preterm labor. J Reprod Med 46 (2001) 232-236
74. Hack C.E., and Zeerleder S. The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 29 (2001) S21-S27
75. Hack M., Taylor H.G., Drotar D., Schluchter M., Cartar L., Andreias L., et al. Chronic condition, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s. JAMA 294 (2005) 318-325
76. Hagberg H. No correlation between cerebral palsy and cytokines in postnatal blood of preterms. Pediatr Res 53 (2003) 544-545
77. Hagberg H., and Malard C. Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 18 (2005) 117-123
78. Hagberg H., Dammann O., Mallard C., and Leviton A. Preconditioning and the developing brain. Semin Perinatol 28 (2004) 389-395
79. Hakak Y., Walker J.R., Li C., Wong W.H., Daus K.L., Buxbaum J.D., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98 (2001) 4746-4751
80. Hansen-Pupp I., Harling S., Berg A.-C., Cilio C., Hellstrom-Westas L., and Ley D. Circulating interferon-gamma and white matter brain damage in preterm infants. Pediat Res 58 (2005) 946-952
81. Harding D., Dhamrait S., Millar A., Humphries S., Marlow N., Whitelaw A., et al. Is interleukin-6-174 genotype associated with the development of septicemia in preterm infants?. Pediatrics 112 (2003) 800-803
82. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10 (2005) 40-68
83. Haynes R.L., Baud O., Li J., Kinney H.C., Volpe J.J., and Folkerth D.R. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol 15 (2005) 225-233
84. Hof P.R., Haroutunian V., Friedrich Jr. V.L., Byne W., Buitron C., Perl D.P., et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53 (2003) 1075-1085
85. Hume D.A., Perry V.H., and Gordon S. Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol 97 (1983) 253-257
86. Ikeda T., Yang L., Ikenoue T., Mallard C., and Hagberg H. Endotoxin-induced hypoxic-ischemic tolerance is mediated by up-regulation of corticosterone in neonatal rat. Pediatr Res 59 (2006) 56-60
87. Inder T., Neil J., Yoder B., and Rees S. Patterns of cerebral injury in a primate model of preterm birth and neonatal intensive care. J Child Neurol 20 (2005) 965-967
88. Inder T., Wells S., Mogridge M., Spenser C., and Volpe J. Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study. J Pediatr 143 (2003) 171-179
89. Ivanova A., Nakahia E., Kagawa T., Oba A., Wada T., Takebayashi H., et al. Evidence for a second wave of oligodendrogenesis in the postnatal cerebral cortex of the mouse. J Neurosci Res 73 (2002) 581-592
90. Jakovcevski I., and Zecevic N. Sequence of oligodendrocyte development in the human fetal telencephalon. Glia 49 (2005) 480-491
91. Juul-Dam N., Townsend J., and Courchesne E. Prenatal, perinatal, and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population. Pediatrics 107 (2001) E63
92. Kaifu T., Nakahara J., Inui M., Mishima K., Momiyama T., Kaji M., et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 111 (2003) 323-332
93. Katsel P., Davis K.L., Gorman J.M., and Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophr Res 77 (2005) 241-252
94. Katsel P., Davis K.L., and Haroutunian V. Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int Rev Neurobiol 63 (2005) 41-82
95. Katsel P., Davis K.L., and Haroutunian V. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res 79 (2005) 157-173
96. Kennedy M.L., Torrance D.S., Picha K.S., and Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis revels that IL-10 mRNA expression correlated with recovery. J Immunol 149 (1992) 2496-2505
97. Kesler S.R., Ment L.R., Vohr B., Pajot S.K., Schneider K.C., Katz K.H., et al. Volumetric analysis of regional cerebral development in preterm children. Pediatr Neurol 31 (2004) 318-325
98. Kessaris N., Jamen F., Rubin L., and Richardson W.D. Cooperation between sonic hedgehog and fibroblast growth factor/MAPK signaling pathways in neocortical precursors. Development 131 (2004) 1289-1298
99. Kinney H.C., and Back S.A. Human oligodendroglial development: relationship to periventricular leukomalacia. Semin Pediatr Neurol 5 (1998) 180-189
100. Kipnis J., Cardon M., Strous R.D., and Schwartz M. Loss of autoimmune T cells correlates with brain diseases: possible implications for schizophrenia. Trends Mol Med 12 (2006) 107-112
101. Krause I., He X.-S., Gershwin M.E., and Shoenfeld Y. Brief report: immune factors in autism: a critical review. J Autism Dev Dis 32 (2002) 337-345
102. Korvatska E., Van de Water J., Anders T.F., and Gershwin M.E. Genetic and immunologic considerations in autism. Neurobiol Dis 9 (2002) 107-125
103. Kronfol Z., and Remick D.G. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157 (2000) 683-694
104. Kuban K.C., and Leviton A. Cerebral palsy. N Engl J Med 330 (1994) 188-195
105. Lainhart J.E. Advances in autism neuroimaging research for the clinician and geneticist. Am J Med Genet 142 (2006) 33-39
106. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33 (2003) 366-374
107. Lefebvre F., Glorieux J., and St-Laurent-Gasgnon T. Neonatal survival and disability rate at age 18 months for infants born between 23 and 28 weeks of gestation. Am J Obstet Gyn 174 (1996) 833-838
108. Ling Z., Chang Q., Tong C., Leurgans S., Lipton J., and Carvey P. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp Neurol 190 (2004) 373-383
109. Ling Z., Gayle D., Ma S., Lipton J., Tong C., Hong J., et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 17 (2002) 116-124
110. Lu G.C., and Goldenberg R.L. Current concepts on the pathogenesis and markers of preterm births. Clin Perinatol 27 (2000) 263-283
111. Ludwin S.K. The function of perineuronal satellite oligodendrocytes: an immunohistochemical study. Neuropathol Appl Neurobiol 10 (1984) 143-149
112. Majde J.A. Viral double-stranded RNA, cytokines, and the flu. J Interferon Cytokine Res 20 (2000) 259-272
113. Mallard C., Welin A.K., Peebles D., Hagberg H., and Kjellmer I. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res 28 (2003) 215-223
114. Marin-Padilla M. Early vascularization of the embryonic cerebral cortex: golgi and electron microscopic studies. J Comp Neurol 241 (1985) 237-249
115. Marin-Padilla M. Embryonic vascularization of the mammalian cerebral cortex. In: Peters A., and Jones E.G. (Eds). Cerebral cortex vol. 7 (1988), Plenum, New York 479-509
116. Martin J.A., Hamilton B.E., Sutton P.D., Ventura S.J., Menacker F., and Munson M.L. Births: final data for 2002. Natl Vital Sat Rep 52 (2003) 1-113
117. Martinez E., Figueroa M.E., Garry D., Visintainer P., Pater K., Verma U., et al. Elevated amniotic fluid interleukin-6 as a predictor of neonatal periventricular leukomalacia and intraventricular hemorrhage. J Maternal-Fetal Invest 8 (1998) 101-107
118. McCarley R.W., Wible C.G., Frumin M., Hirayasu Y., Levitt J.J., Fischer I.A., et al. MRI anatomy of schizophrenia. Biol Psychiatry 45 (1999) 1099-1119
119. McGuffin P., Owen M.J., and Farmer A.E. Genetic basis of schizophrenia. Lancet 346 (1995) 678-682
120. McQuillen P.S., and Ferriero D.M. Selective vulnerability in the developing central nervous system. Pediatr Neurol 30 (2004) 227-235
121. Meng X., Brown J.M., Ao L., Rowland R.T., Nordeen S.K., Banerjee A., et al. Myocardial gene reprogramming associated with a cardiac cross-resistant state induced by LPS preconditioning. Am J Physiol 275 (1998) C475-C483
122. Miller S.P., Ferriero D.M., Leonard C., Piecuch R., Glidden D.V., Partridge J.C., et al. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr 147 (2005) 609-616
123. Molina-Holgado E., Vela J.M., Arevalo-Martin A., and Guaza C. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci 13 (2001) 493-502
124. Mortensen P.B., Pedersen C.B., Westergaard T., Wohlfhart J., Ewald H., Mors O., et al. Effects of family history and place and season of birth on the risk of schizophrenia. New Engl J Med 340 (1999) 603-608
125. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
126. Nandagopal K., Dawson T.M., and Dawson V.L. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther 297 (2001) 474-478
127. Nawa H., Takahashi M., and Patterson P.H. Cytokine and growth factor involvement in schizophrenia-support for the developmental model. Mol Psychiatry 5 (2000) 594-603
128. Nelson K.B., and Willoughby E.R. Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 13 (2000) 133-139
129. Noy S., Achiron A., and Laor N. Schizophrenia and autoimmunity-a possible etiological mechanism?. Neuropsychobiology 30 (1994) 157-159
130. Olsen P., Vainionpaa L., Paakko E., Korkman M., Pyhtimen J., and Jarvelin M. Psychological findings in preterm children related to neurologic status and magnetic resonance imaging. Pediatrics 102 (1996) 329-336
131. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., and Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59 (2006) 546-554
132. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenia. Arch Gen Psychiatry 47 (1990) 1023-1028
133. Pantelis C., Barnes T., and Nelson H. Is the concept of frontal-subcortical dementia relevant to schizophrenia?. Brit J Psychiatry 160 (1992) 442-460
134. Pantelis C., Yucel M., Wood S.J., Velakoulis D., Sun D., Berger G., et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 31 (2005) 672-696
135. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 12 (2002) 115-118
136. Pearlson G. Neurobiology of schizophrenia. Ann Neurol 48 (2000) 556-566
137. Peterson B., Vohr B., Staib L.H., Cannistraci C.J., Dolberg A., Schneider K.C., et al. Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 284 (2000) 1939-1947
138. Plioplys A.V., Greaves A., Kazemi K., and Silverman E. Lymphocyte function in autism and Rett syndrome. Neuropsychobiology 29 (1994) 12-16
139. Radewicz K., Garey L.J., and Rynolds R. Increase in microglia in frontal and temporal cortex of schizophrenics. Schizophr Res 29 (1998) 86-87
140. Rajkowska G., Selemon L.D., and Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex. A postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 55 (1998) 215-224
141. Rapaport M.H., Torrey E.F., McAllister C.G., Nelson D.L., Pickar D., and Paul S.M. Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur Arch Psychiatry Clin Neurosci 243 (1993) 7-10
142. Remahl S., and Hildebrand C. Relation between axons and oligodendroglial cells during initial myelination. I. The glial unit. J Neurocytol 19 (1990) 313-328
143. Renno T., Krakowski M., Piccirillo C., Lin J.Y., and Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J Immunol 154 (1995) 944-953
144. Resnick M.B., Gomatam S.V., Carter R.L., Ariet M., Roth J., Kilgore K.L., et al. Educational disabilities of neonatal intensive care graduates. Pediatrics 102 (1998) 308-314
145. Richardson W.D., Kessaris N., and Pringle N. Oligodendrocyte wars. Nature Rev Neurosci 7 (2006) 11-18
146. Robinson S. Systemic prenatal insults disrupt telencephalon development: implications for potential interventions. Epilepsy Behav 7 (2005) 345-363
147. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Imunol 85 (2000) 9-18
148. Salafia C.M., Sherer D.M., Spong C.Y., Lencki S., Eglinton G.S., Parkash V., et al. Fetal but not maternal serum cytokine levels correlate with biologic acute placental inflammation. Am J Perinatol 14 (1999) 419-422
149. Saliba E., and Henrot A. Inflammatory mediators and neonatal brain damage. Biol Neonate 79 (2001) 224-227
150. Saliba E., and Marret S. Cerebral white matter damage in the preterm infant: pathophysiology and risk factors. Semin Neonatol 6 (2001) 121-133
151. Sanchez A.R., Kupp L.I., Sheridan P.J., and Sanchez D.R. Maternal chronic infection as a risk factor in preterm low birth weight infants: the link with periodontal infection. J Int Acad Periodontol 6 (2004) 89-94
152. Selemon L.D., Rajkowska G., and Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52 (1995) 805-818
153. Selmaj K., Raine C.S., Farooq M., Norton W.T., and Brosnan C.F. Cytokine cytotoxicity against oligodendrocytes: apoptosis induced by lymphotoxin. J Immunol 147 (1991) 1522-1529
154. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23 (2003) 297-302
155. Skranes J.S., Martinussen M., Smevik O., Myhr G., Indredavik M., Vik T., et al. Cerebral MRI findings in very-low-birth-weight and small-for-gestational-age children at 15 years of age. Pediatr Radiol 35 (2005) 758-765
156. Spinillo A., Capuzzo E., Stromati M., Ometto A., DeSantolo A., and Acciano S. Obstetric risk factors for periventricular leukomalacia among preterm infants. Brit J Obstet Gynecol 105 (1998) 865-871
157. Stark A.K., Uylings H.B., Sanz-Arigita E., and Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 161 (2004) 882-888
158. Stubbs E.G., and Crawford M.L. Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr 7 (1977) 49-55
159. Stubbs E.G., Ash E., and Williams C.P. Autism and congenital cytomegalovirus. J Autism Dev Disord 14 (1984) 183-189
160. Suvisaari J., Haukka J., Tanskanen A., Hovi T., and Lonnqvist J. Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry 156 (1999) 1100-1102
161. Suzumura A., Silberberg D.H., and Lisak R.P. The expression of MHC antigens on oligodendrocytes: induction of polymorphic H-2 expression by lymphokines. J Neuroimmunol 11 (1986) 179-190
162. Svedin P., Kjellmer I., Welin A.K., Blad S., and Mallard C. Maturational effects of lipopolysaccharide on white-matter injury in fetal sheep. J Child Neurol 20 (2005) 960-967
163. Takaoka A., Nakae I., Mitsunami K., Yabe T., Morikawa S., Inubushi T., et al. Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning". J Am Coll Cardiol 33 (1999) 556-564
164. Takashima S., Iida K., and Deguchi K. Periventricular leukomalacia, glial development and myelination. Early Hum Dev 43 (1995) 117-184
165. Tilg H., Dinarello C., and Mier J. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 18 (1997) 428-432
166. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362 (2003) 798-805
167. Traynor T.R., Majde J.A., Bohnet S.G., and Krueger J.M. Intratracheal double stranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections. Life Sci 74 (2004) 2563-2576
168. Tsuang M.T., and Faraone S. The case for heterogeneity in the etiology of schizophrenia. Schizophr Res 17 (1995) 161-175
169. Tucker R. Peridontitis and pregnancy. J R Soc Health 126 (2006) 24-27
170. Urakubo A., Jarskog L.F., Lieberman J.A., and Gilmore J.H. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 47 (2001) 27-36
171. Uranova N.A., Orlovskaya D.D., Vikhreva O.V., Zimina I.S., Kolomeets N.S., Vostrikov V.M., et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 55 (2001) 597-610
172. Uranova N.A., Vostrikov V.M., Orlovskaya D.D., and Rachmanova V.I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67 (2004) 269-275
173. van Furth R. Phagocytic cells: development and distribution of mononuclear phagocytes in normal steady state and inflammation. In: Gallin J.I., Goldstein I.M., and Snyderman R. (Eds). Inflammation. Basic principles and clinical correlates (1988), Raven Press, New York 281-295
174. van Furth R., Cohn Z.A., Hirsch J.G., Humphrey J.H., Spector W.G., and Langevoort H.L. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ 46 (1972) 845-852
175. van Gent T., Heijnen C.J., and Treffers P.D.A. Autism and the immune system. J Child Psychol Psychiatry Allied Discipl 38 (1997) 337-349
176. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (2005) 67-81
177. Vohr B.R., and Msall M.E. Neuropsychological and functional outcomes of very low birth weight infants. Semin Perinatol 21 (1997) 202-220
178. Volpe J.J. Neurologic outcome of prematurity. Archiv Neurol 55 (1998) 297-300
179. Volpe J.J. Neurology of the newborn. 4th ed. (2001), WB Saunders Co., Philadelphia
180. Waddington J.L., Lane A., Scully P.J., Larkin C., and O'Callaghan E. Neurodevelopmental and neuroprogressive processes in schizophrenia: antithetical or complimentary over a lifetime trajectory of disease?. Psychiatry Clin N Am 21 (1998) 123-149
181. Wagner J. Is IL-6 both a cytokine and a neurotrophic factor?. J Exp Med 183 (1996) 2417-2419
182. Walterfang M., Wood S.J., Velakoulis D., Copolov D., and Pantelis C. Diseases of white matter and schizophrenia-like psychosis. Austr New Zeal J Psychiatry 39 (2005) 746-756
183. Warren R.P., Foster A., and Margaretten N.C. Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry 26 (1987) 333-335
184. Warren R.P., Margaretten N.C., Pace N.C., and Foster A. Immune abnormalities in patients with autism. J Autism Dev Disord 16 (1986) 189-197
185. Wong G.H.W., Barteltt P.F., Clark-Lewis I., Battye F., and Schrader J.W. Inducible expression of H-2 and Ia antigens on brain cells. Nature 310 (1984) 688-691
186. Wood N.S., Marlow N., Costerloe K., Gibson A.T., and Wilkinson A.R. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. New Engl J Med 343 (2000) 378-384
187. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., and Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157 (2000) 16-25
188. Yolken R.H., Karlsson H., Yee F., Johnston-Wilson N.L., and Torrey E.F. Endogenous retroviruses and schizophrenia. Brain Res Brain Res Rev 31 (2000) 193-199
189. Yoon B.H., Jun J.K., Romero R., Park K.L., Gomez R., Choi J., et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions and cerebral palsy. Am J Obstet Gynecol 177 (1997) 19-26
190. Yoon B.H., Romero R., Kim C.J., Jun J.K., Gomez R., Choi J.-H., et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gyn 172 (1995) 960-970
191. Zimmerman A.W., Jyonouchi H., Comi A.M., Connors S.L., Milstien S., Varsou A., et al. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 33 (2005) 195-201
192. Zuckerman L., Rehavi M., Nachman R., and Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28 (2003) 1778-1789